Results 261 to 270 of about 1,479,789 (367)

Unraveling the crucial role of CCL3 in nasopharyngeal carcinoma: bioinformatics and immunohistochemical insights. [PDF]

J Pathol Transl Med
Guo X, Sun Z, Liang Y, Chang A, Ling J, Zhao H, Zhuo X.   +6 more
europepmc   +1 more source

Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo.

, 1991
Kevin J. Gilligan, Pathmanathan Rajadurai, Jung‐Chung Lin, Pierre Busson, Mohamed Abdel-Hamid, U. Prasad, Thomas Tursz, Nancy Raab‐Traub   +7 more
openalex   +2 more sources

Mitochondrial Microproteins: Emerging Regulators in Neurodevelopment and Neurodegeneration

BioEssays, Volume 47, Issue 10, October 2025.
Mitochondrial microproteins have emerged as critical regulators of mitochondrial function. Neurons are highly dependent on mitochondria to sustain their function. Mitochondrial microproteins can be deregulated and can contribute to the pathogenesis of neurodegenerative disorders. Mitochondrial microproteins are involved in neuronal development. However,
Nada Borghol, Sozerko Yandiev, Julien Courchet   +2 more
wiley   +1 more source

Bladder metastasis of nasopharyngeal carcinoma: A rare case report and literature review. [PDF]

Urol Case Rep
Shi BF, Zhang YD.
europepmc   +1 more source

Reduction Operation for the Patients with Recurrent of Persistent Nasopharyngeal Carcinoma.

, 1991
Hitoshi Tojima, You Kimura, Tadashi Nakamura, Yoshio Koike   +3 more
openalex   +2 more sources

Association Between Metabolic Syndrome and Its Components and the Risk of Head and Neck Cancer: A Systematic Review and Meta‐Analysis

Cancer Medicine, Volume 14, Issue 19, October 2025.
ABSTRACT Background The relationship between metabolic syndrome (MetS) and head and neck cancer (HNC) remains controversial. The present meta‐analysis evaluated the association between MetS and the risk of developing HNC. Methods A literature search was conducted across various databases, including Embase, Cochrane, PubMed, and Web of Science, to ...
Qingling Wang, Shiduo Guo, Ruizhe Huang, Zhenju Xu, Dapeng Liang, Yichuan Huang, Yubo Sun, Weiqi Yang, Liwei Jiang   +8 more
wiley   +1 more source

Results of chemo-radiotherapy for nasopharyngeal carcinoma.

, 1991
Gentaro Mizojiri, Yuko Shiba, Kenzo Inoue, Tetsuo Hoshino, TOSHITSUGU NOZAKI, Kozo Yamada   +5 more
openalex   +2 more sources

Heterogeneity of HLA and EBER expression in epstein-barr virus-associated nasopharyngeal carcinoma [PDF]

, 2000
Yunhong Yao, Helena A. Minter, Xiaoyi Chen, Gary Reynolds, Michael Bromley, J. R. Arrand   +5 more
openalex   +1 more source

LAG3 as a Tumor Suppressor and Immune Regulator in Cervical Cancer: From Functional Validation to Therapeutic Strategy

Cancer Medicine, Volume 14, Issue 19, October 2025.
Studies have found that the molecular typing of pyroptostic‐related genes (PRGs) in cervical cancer can predict prognosis, and the GNAZ/LAG3/IL1B/CA2/SPRR3 risk scoring model has been constructed. Experiments have confirmed that LAG3 inhibits tumor progression by regulating Treg and CD8+ T cells, providing a new target for immunotherapy.
Shijie Yao, Siming Chen, Shimeng Wan, Anjin Wang, Ziyan Liang, Xuelian Liu, Yang Gao, Hongbing Cai   +7 more
wiley   +1 more source

Integrating Radiomics and Deep-Learning for Prognostic Evaluation in Nasopharyngeal Carcinoma. [PDF]

Medicina (Kaunas)
Pușcaș IM, Gâta A, Roman A, Albu S, Gâta VA, Irimie A.   +5 more
europepmc   +1 more source